# FDA Inspection 1164224 - Octapharma Plasma Inc - February 24, 2022

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/054d4a8e-421c-43d2-9525-d02ad2d76ee6
Source feed: FDA_Inspections

> FDA Inspection 1164224 for Octapharma Plasma Inc on February 24, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1164224
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2022-02-24
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1164224 - 2022-02-24](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/562699dd-7fd1-459e-982b-9886a9cdf191)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/fb6132be-631d-4e1c-a10c-b95018676cbb

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d